Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01039311 · ClinicalTrials.gov registry record
Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer
A clinical trial, sponsored by University of Oklahoma.
- Terminated
- Registry status
- 16
- Enrollment target
NCT01039311 is a clinical trial that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 16 participants.
The verdict
NCT01039311 was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- 16 participants
- Enrollment target
Study Summary
Optical coherence tomography will be a feasible adjunct to flexible bronchoscopy, and provide images with good sensitivity and specificity to determine the presence of endobronchial malignancies.
Interventions
- DEVICE Optical Coherence Tomography
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2009-02 |
| Est. Completion | 2012-09 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01039311
The ClinicalTrials.gov registry entry for NCT01039311 describes a study currently listed as terminated, categorized as an unspecified phase. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Optical Coherence Tomography is the first listed.
NCT01039311 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01039311 about?
NCT01039311 is a clinical study titled "Optical Coherence Tomography: An Adjunct to Flexible Bronchoscopy in the Diagnosis of Lung Cancer". Optical coherence tomography will be a feasible adjunct to flexible bronchoscopy, and provide images with good sensitivity and specificity to determine the presence of endobronchial malignancies.
What is the current status of trial NCT01039311?
This trial is currently terminated. The enrollment target is 16 participants. The study started on 2009-02. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01039311?
The interventions under investigation include: Optical Coherence Tomography (DEVICE).
Who is sponsoring clinical trial NCT01039311?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.